×
About 1,715 results

ALLMedicine™ Liver Diseases Center

Research & Reviews  757 results

Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Mi...
https://doi.org/10.1053/j.gastro.2020.11.035
Gastroenterology Adeniji N, Carr RM et. al.

Nov 23rd, 2020 - Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities with Chronic Liver Diseases (CLD).|2020|Adeniji N,Carr RM,Aby ES,Catana AM,Wegermann K,|

Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, Chin...
https://doi.org/10.1002/jmv.26663
Journal of Medical Virology REFERENCES; Wang J, Zhu L et. al.

Nov 11th, 2020 - We aimed to describe liver injury and identify the risk factors of liver injury in coronavirus disease (COVID-19) patients without chronic liver diseases (CLD). The clinical data of 228 confirmed COVID-19 patients without CLD were retrospectively ...

De novo and recurrent liver disease.
https://doi.org/10.1016/j.bpg.2020.101688
Best Practice & Research. Clinical Gastroenterology; Ip S, Bhanji RA et. al.

Nov 7th, 2020 - Decompensated cirrhosis due to nonalcoholic steatohepatitis (NASH), and autoimmune liver diseases (AILD) are the most common indications for liver transplantation (LT). AILD include autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), an...

FibroMeter scores for the assessment of liver fibrosis in patients with autoimmune live...
https://doi.org/10.1016/j.aohep.2020.10.013
Annals of Hepatology; Zachou K, Lygoura V et. al.

Nov 6th, 2020 - We assessed FibroMeter virus (FMvirus) and FibroMeter vibration-controlled transient elastography (FMVCTE) in 134 patients with autoimmune liver diseases [ALD, autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC)], in order to assess n...

Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspec...
https://doi.org/10.1007/s40264-020-01014-2
Drug Safety; Treem WR, Palmer M et. al.

Nov 3rd, 2020 - With the widespread development of new drugs to treat chronic liver diseases (CLDs), including viral hepatitis and nonalcoholic steatohepatitis (NASH), more patients are entering trials with abnormal baseline liver tests and with advanced liver in...

see more →

Guidelines  7 results

Optimization of the transition process of youth with liver disease in adulthood: A posi...
https://doi.org/10.1016/j.clinre.2019.07.018
Clinics and Research in Hepatology and Gastroenterology; Antonini TM, Girard M et. al.

Sep 30th, 2019 - Transition describes a progressive and highly coordinated process encompassing the transfer of a young patient from paediatric care to the adult-care system. Transfer of medical care for an adolescent to adult services is a complex and challenging...

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the St...
https://www.aasld.org/sites/default/files/guideline_documents/PracticeGuidelines-PBC-November2018.pdf

Oct 31st, 2018 - This American Association for the Study of Liver Diseases (AASLD) 2018 Practice Guidance on Primary Biliary Cholangitis (PBC) is an update of the PBC guidelines published in 2009. The 2018 updated guidance on PBC includes updates on etiology and d.

Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Trea...
https://www.aasld.org/sites/default/files/PracticeGuidelines-HCV-November2018.pdf
AASLD-IDSA HCV Guidance Panel

Oct 29th, 2018 - Recognizing the importance of timely guidance regarding the rapidly evolving field of hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) developed a web-ba.

Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Live...
https://doi.org/10.1159/000368141
Oncology Kudo M, Matsui O et. al.

Nov 27th, 2014 - Surveillance and diagnostic algorithms for hepatocellular carcinoma (HCC) have already been described in guidelines published by the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver ...

Hepatocellular carcinoma: illustrated guide to systematic radiologic diagnosis and stag...
https://doi.org/10.1148/rg.336125104
Radiographics : a Review Publication of the Radiological Society of North America, Inc; McEvoy SH, McCarthy CJ et. al.

Oct 10th, 2013 - Hepatocellular carcinoma is a malignancy that predominantly occurs in the setting of cirrhosis. Its incidence is rising worldwide. Hepatocellular carcinoma differs from most malignancies because it is commonly diagnosed on the basis of imaging fea...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  851 results

Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Mi...
https://doi.org/10.1053/j.gastro.2020.11.035
Gastroenterology Adeniji N, Carr RM et. al.

Nov 23rd, 2020 - Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities with Chronic Liver Diseases (CLD).|2020|Adeniji N,Carr RM,Aby ES,Catana AM,Wegermann K,|

Semaglutide Shows Promise in NASH Phase 2 Study
https://www.medscape.com/viewarticle/940975

Nov 12th, 2020 - Almost 60% of patients with biopsy-confirmed nonalcoholic steatohepatitis and liver fibrosis showed resolution of NASH after treatment with semaglutide,according to a phase 2, double-blind, randomized, placebo-controlled trial published in the New...

Risk Factors Can Help Spot People Who Need Hep D Screening
https://www.medscape.com/viewarticle/940855

Nov 12th, 2020 - NEW YORK (Reuters Health) - Several risk factors associated with hepatitis D virus (HDV) infection can be used to identify people who should be screened, researchers report. "It was interesting to find that the risk factors that were identified in...

Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, Chin...
https://doi.org/10.1002/jmv.26663
Journal of Medical Virology REFERENCES; Wang J, Zhu L et. al.

Nov 11th, 2020 - We aimed to describe liver injury and identify the risk factors of liver injury in coronavirus disease (COVID-19) patients without chronic liver diseases (CLD). The clinical data of 228 confirmed COVID-19 patients without CLD were retrospectively ...

De novo and recurrent liver disease.
https://doi.org/10.1016/j.bpg.2020.101688
Best Practice & Research. Clinical Gastroenterology; Ip S, Bhanji RA et. al.

Nov 7th, 2020 - Decompensated cirrhosis due to nonalcoholic steatohepatitis (NASH), and autoimmune liver diseases (AILD) are the most common indications for liver transplantation (LT). AILD include autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), an...

see more →

News  97 results

Semaglutide Shows Promise in NASH Phase 2 Study
https://www.medscape.com/viewarticle/940975

Nov 12th, 2020 - Almost 60% of patients with biopsy-confirmed nonalcoholic steatohepatitis and liver fibrosis showed resolution of NASH after treatment with semaglutide,according to a phase 2, double-blind, randomized, placebo-controlled trial published in the New...

Risk Factors Can Help Spot People Who Need Hep D Screening
https://www.medscape.com/viewarticle/940855

Nov 12th, 2020 - NEW YORK (Reuters Health) - Several risk factors associated with hepatitis D virus (HDV) infection can be used to identify people who should be screened, researchers report. "It was interesting to find that the risk factors that were identified in...

Treating Liver Disease During COVID-19: New Recommendations
https://www.staging.medscape.com/viewarticle/930411

May 13th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The COVID-19 pandemic presents myriad challenges to hepatologists, gastroenterologists, transplant programs, primary care providers, and, of course, their patien...

Treating Liver Disease During COVID-19: New Recommendations
https://www.medscape.com/viewarticle/930411

May 13th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The COVID-19 pandemic presents myriad challenges to hepatologists, gastroenterologists, transplant programs, primary care providers, and, of course, their patien...

Fast Five Quiz: Nonalcoholic Steatohepatitis (NASH)
https://reference.staging.medscape.com/viewarticle/929475_6

May 10th, 2020 - Weight loss is a recommended treatment strategy for NASH. The American Association for the Study of Liver Diseases (AASLD) indicate that a 3%-5% weight loss reduces hepatic steatosis, but that up to a 10% weight loss might be needed to improve nec...

see more →

Patient Education  2 results see all →